Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis.

Documenti analoghi

• Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy.
  di: Maini, R, et al.
  Pubblicazione: (2000)
• Anti-tumor necrosis factor alpha therapy of rheumatoid arthritis. Mechanism of action.
  di: Feldmann, M, et al.
  Pubblicazione: (1997)
• Selective immunosuppression of tumour necrosis factor-alpha in rheumatoid arthritis.
  di: Brennan, F, et al.
  Pubblicazione: (1995)
• Use of anti-tumor necrosis factor antibodies in rheumatoid arthritis.
  di: Feldmann, M, et al.
  Pubblicazione: (1994)
• How does infliximab work in rheumatoid arthritis?
  di: Maini, R, et al.
  Pubblicazione: (2002)